Skip to main content

Disease management

By Jessica Hagen | 12:18 pm | March 24, 2023
The AI-powered app allows for remote monitoring of common Parkinson's disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch.
By Jessica Hagen | 10:52 am | March 23, 2023
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
By Jessica Hagen | 10:52 am | March 23, 2023
A study published in The New England Journal of Medicine found a closed-loop control system kept children's glucose levels in the target range longer than standard care.
By Emily Olsen | 02:00 pm | March 22, 2023
The program will be available through Amwell in the second half of 2023.
By Jessica Hagen | 11:32 am | March 21, 2023
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
By Jessica Hagen | 01:59 pm | March 16, 2023
The funds will be used to accelerate the adoption of the platform's applied behavior analysis-focused tools.
By Jessica Hagen | 02:28 pm | March 14, 2023
BlueRock Therapeutics will utilize Rune Labs' StriveStudy clinical trial platform and FDA-cleared Apple Watch data-collection tool to monitor Parkinson's disease.
By Adam Ang | 08:00 am | March 13, 2023
The wearable device directly measures respiration to predict deterioration in COPD patients. 
By Jessica Hagen | 01:41 pm | March 10, 2023
Viz.ai also announced an agreement with Bristol Myers Squibb to identify patients with hypertrophic cardiomyopathy.
By Adam Ang | 10:39 pm | February 23, 2023
Also, medical device unicorn Molbio has taken a 70% stake in digital x-ray manufacturer Prognosys.